发明名称 Sustained-release liposomal anesthetic compositions
摘要 The invention provides a method for obtaining local anesthetics encapsulated in liposomes, such as multi vesicular liposomes, with high encapsulation efficiency and slow release in vivo. When the encapsulated anesthetic is administered as a single intracutaneous dose, the duration of anesthesia and half-life of the drug at the local injection site is increased as compared to injection of unencapsulated anesthetic. The maximum tolerated dose of the encapsulated anesthetic is also markedly increased in the liposomal formulation over injection of unencapsulated anesthetic. These results show that the liposomal formulation of local anesthetic is useful for sustained local infiltration and nerve block anesthesia.
申请公布号 US8834921(B2) 申请公布日期 2014.09.16
申请号 US201213476823 申请日期 2012.05.21
申请人 Pacira Pharmaceuticals, Inc. 发明人 Kim Sinil;Kim Taehee;Murdande Sharad
分类号 A61K9/127;A61K9/00;A61K47/12;A61K47/02;A61K31/40;A61K31/445;A61K31/167 主分类号 A61K9/127
代理机构 Knobbe Martens Olson & Bear LLP 代理人 Knobbe Martens Olson & Bear LLP
主权项 1. A process for making a multivesicular liposome formulation comprising bupivacaine phosphate comprising: a) preparing a first aqueous component comprising at least one acid in sufficient quantity to solubilize bupivacaine or a salt thereof, said acid being phosphoric acid; b) preparing a lipid component comprising at least one organic solvent, at least one amphipathic lipid, and at least one neutral lipid lacking a hydrophilic head group; c) mixing said first aqueous component and said lipid component to form a water-in-oil emulsion, wherein at least one component comprises bupivacaine or a salt thereof; d) mixing said water-in-oil emulsion with a second aqueous component to form solvent spherules; and e) removing the organic solvent from the solvent spherules to form multivesicular liposomes.
地址 San Diego CA US